Other related literature notes that a cervical cancer nanoparticle vaccine could introduce the heat shock protein (HSP)110 gene into tumor cells, which strongly improved the epitope-specific immunogenicity in vitro and in vivo, induced the proliferation of T lymphocytes and significantly enhanced the antigen-specific CTL response and its cytotoxic effect. The gene discussed is HSPH1; the disease is cervical carcinoma.